Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I-II GIMEMA trial.

Mauro FR, Carella AM, Molica S, Paoloni F, Liberati AM, Zaja F, Belsito V, Cortellezzi A, Rizzi R, Tosi P, Spriano M, Ferretti A, Nanni M, Marinelli M, De Propris MS, Orlando SM, Vignetti M, Cuneo A, Guarini AR, Foà R.

Leuk Lymphoma. 2017 Jul;58(7):1640-1647. doi: 10.1080/10428194.2016.1258698. Epub 2016 Nov 23.

PMID:
27881039
2.

Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.

Gentile M, Cutrona G, Fabris S, Pesce EA, Baldini L, Di Raimondo F, Musolino C, Di Tonno P, Di Renzo N, Molica S, Brugiatelli M, Ilariucci F, Zupo S, Matis S, Maura F, Vigna E, Angrilli F, Recchia AG, Quarta G, Iannitto E, Fragasso A, Musto P, Spriano M, Vincelli I, Vallisa D, Cortelezzi A, Mauro FR, Foà R, Federico M, Neri A, Ferrarini M, Morabito F.

Am J Hematol. 2013 Jul;88(7):539-44. doi: 10.1002/ajh.23448. Epub 2013 Jun 12.

3.

An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia.

Montillo M, Tedeschi A, Petrizzi VB, Ricci F, Crugnola M, Spriano M, Spedini P, Ilariucci F, Uziel L, Attolico I, Vismara E, De Blasio A, Zaccaria A, Morra E.

Blood. 2011 Oct 13;118(15):4079-85. doi: 10.1182/blood-2011-05-351833. Epub 2011 Jul 19.

4.

Therapy of Hodgkin's lymphoma in clinical practice: A retrospective long-term follow-up analysis.

Aquino S, Clavio M, Rossi E, Vignolo L, Miglino M, Spriano M, Canepa L, Catania G, Pierri I, Bergamaschi M, Gonella R, Marani C, Racchi O, Cavaliere M, Goretti R, Carbone F, Bruzzone A, Tassara R, Carella AM, Ghio R, Gobbi M.

Oncol Lett. 2011 Mar;2(2):289-295. Epub 2011 Jan 21.

5.

Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletion.

Mosca L, Fabris S, Lionetti M, Todoerti K, Agnelli L, Morabito F, Cutrona G, Andronache A, Matis S, Ferrari F, Gentile M, Spriano M, Callea V, Festini G, Molica S, Deliliers GL, Bicciato S, Ferrarini M, Neri A.

Clin Cancer Res. 2010 Dec 1;16(23):5641-53. doi: 10.1158/1078-0432.CCR-10-0151. Epub 2010 Oct 14.

6.

Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma.

Corso A, Barbarano L, Mangiacavalli S, Spriano M, Alessandrino EP, Cafro AM, Pascutto C, Varettoni M, Bernasconi P, Grillo G, Carella AM, Montalbetti L, Lazzarino M, Morra E.

Leuk Lymphoma. 2010 Feb;51(2):236-42. doi: 10.3109/10428190903452826.

PMID:
20001242
7.

Prognostic relevance of in vitro response to cell stimulation via surface IgD in binet stage a CLL.

Morabito F, Cutrona G, Gentile M, Fabbi M, Matis S, Colombo M, Reverberi D, Megna M, Spriano M, Callea V, Vigna E, Rossi E, Lucia E, Festini G, Zupo S, Molica S, Neri A, Ferrarini M.

Br J Haematol. 2010 Apr;149(1):160-3. doi: 10.1111/j.1365-2141.2009.08032.x. Epub 2009 Dec 8. No abstract available.

PMID:
19995391
8.

The case of SLE associated Sneddon-Wilkinson pustular disease successfully and safely treated with infliximab.

Naretto C, Baldovino S, Rossi E, Spriano M, Roccatello D.

Lupus. 2009 Aug;18(9):856-7. doi: 10.1177/0961203309103053. No abstract available.

9.

Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia.

Morabito F, Cutrona G, Gentile M, Matis S, Todoerti K, Colombo M, Sonaglio C, Fabris S, Reverberi D, Megna M, Spriano M, Lucia E, Rossi E, Callea V, Mazzone C, Festini G, Zupo S, Molica S, Neri A, Ferrarini M.

Br J Haematol. 2009 Jun;146(1):44-53. doi: 10.1111/j.1365-2141.2009.07703.x. Epub 2009 May 6.

PMID:
19438486
10.

Seventeen years of experience with ATRA-based therapy for acute promyelocytic leukaemia: long-term follow-up of patients treated at S. Martino Hospital, Genoa.

Clavio M, Ghiso A, Ghiggi C, Spriano M, Colombo N, Grasso R, Varaldo R, Miglino M, Pierri I, Olcese F, Aquino S, Biasco S, Balleari E, Carella AM, Sessarego M, Gobbi M.

Oncol Rep. 2009 Apr;21(4):1045-52.

PMID:
19288007
11.

The addition of radiotherapy to chemotherapy does not improve outcome of early stage Hodgkin's lymphoma patients: a retrospective long-term follow-up analysis of a regional Italian experience.

Olcese F, Clavio M, Rossi E, Spriano M, Ballerini F, Canepa L, Pierri I, Aquino S, Varaldo R, Manna A, Secondo V, Racchi O, Balleari E, Orcioni GF, Carella AM, Ghio R, Gobbi M.

Ann Hematol. 2009 Sep;88(9):855-61. doi: 10.1007/s00277-009-0699-5. Epub 2009 Feb 3.

PMID:
19189105
12.

Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia.

Fabris S, Mosca L, Todoerti K, Cutrona G, Lionetti M, Intini D, Matis S, Colombo M, Agnelli L, Gentile M, Spriano M, Callea V, Festini G, Molica S, Lambertenghi Deliliers G, Morabito F, Ferrarini M, Neri A.

Genes Chromosomes Cancer. 2008 Sep;47(9):781-93. doi: 10.1002/gcc.20579.

PMID:
18521849
13.

Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.

Cutrona G, Colombo M, Matis S, Fabbi M, Spriano M, Callea V, Vigna E, Gentile M, Zupo S, Chiorazzi N, Morabito F, Ferrarini M.

Haematologica. 2008 Mar;93(3):413-22. doi: 10.3324/haematol.11646. Epub 2008 Feb 20.

14.

The presence of high-risk chromosome aberrations in chronic lymphocytic leukaemia does not correlate with centrosome aberrations.

Ottaggio L, Zunino A, Maric I, Grozio A, Rossi E, Spriano M, Viaggi S.

Hematol Oncol. 2008 Mar;26(1):39-42.

PMID:
18050363
15.

Laparoscopic lymph node biopsy in intra-abdominal lymphoma: high diagnostic accuracy achieved with a minimally invasive procedure.

Casaccia M, Torelli P, Cavaliere D, Panaro F, Nardi I, Rossi E, Spriano M, Bacigalupo A, Gentile R, Valente U.

Surg Laparosc Endosc Percutan Tech. 2007 Jun;17(3):175-8.

PMID:
17581460
16.

Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients.

Pozzi S, Marcheselli R, Sacchi S, Baldini L, Angrilli F, Pennese E, Quarta G, Stelitano C, Caparotti G, Luminari S, Musto P, Natale D, Broglia C, Cuoghi A, Dini D, Di Tonno P, Leonardi G, Pianezze G, Pitini V, Polimeno G, Ponchio L, Masini L, Musso M, Spriano M, Pollastri G; Gruppo Italiano Studio Linfomi.

Leuk Lymphoma. 2007 Jan;48(1):56-64.

PMID:
17325848
17.

Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.

Balleari E, Rossi E, Clavio M, Congiu A, Gobbi M, Grosso M, Secondo V, Spriano M, Timitilli S, Ghio R.

Ann Hematol. 2006 Mar;85(3):174-80. Epub 2006 Jan 12.

PMID:
16408206
18.

Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG.

Olivieri A, Santini G, Patti C, Chisesi T, De Souza C, Rubagotti A, Aversa S, Billio A, Porcellini A, Candela M, Centurioni R, Congiu AM, Brunori M, Nati S, Spriano M, Vimercati R, Marino G, Contu A, Tedeschi L, Majolino I, Crugnola M, Sertoli MR; NHLCSG.

Ann Oncol. 2005 Dec;16(12):1941-8. Epub 2005 Sep 12.

PMID:
16157621
19.

Bortezomib (Velcade) for progressive myeloma after autologous stem cell transplantation and thalidomide.

Musto P, Falcone A, Sanpaolo G, Guglielmelli T, Zambello R, Balleari E, Catalano L, Spriano M, Cavallo F, La Sala A, Mantuano S, Nobile M, Melillo L, Scalzulli PR, Dell'Olio M, Bodenizza C, Greco MM, Carella AM Jr, Merla E, Carella AM, Boccadoro M, Cascavilla N, Palumbo A.

Leuk Res. 2006 Mar;30(3):283-5. Epub 2005 Aug 18.

20.

Fludarabine, cyclophosphamide and mitoxantrone for untreated follicular lymphoma: a report from the non-Hodgkin's lymphoma co-operative study group.

Santini G, Chisesi T, Nati S, Porcellini A, Zoli V, Rizzoli V, Zupo S, Marino G, Rubagotti A, Polacco A, Spriano M, Vimercati R, Congiu AM, Ravetti JL, Aversa S, Candela M, Patti C.

Leuk Lymphoma. 2004 Jun;45(6):1141-7.

PMID:
15359993
21.

Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.

Morabito F, Mangiola M, Rapezzi D, Zupo S, Oliva BM, Ferraris AM, Spriano M, Rossi E, Stelitano C, Callea V, Cutrona G, Ferrarini M.

Haematologica. 2003 Aug;88(8):864-73.

22.

Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression.

Ottaggio L, Viaggi S, Zunino A, Zupo S, Rossi E, Spriano M, Abbondandolo A, Ferrarini M.

Haematologica. 2003 Jul;88(7):769-77.

23.

Risk of second cancer in patients with hairy cell leukemia: long-term follow-up.

Federico M, Zinzani PL, Frassoldati A, Vinceti M, Modè A, Annino L, Chisesi T, Pagnucco G, Invernizzi R, Spriano M, Resegotti L, Bendandi M, Damasio EE; Italian Cooperative Group for the Study of Hairy Cell Leukemia.

J Clin Oncol. 2002 Feb 1;20(3):638-46.

PMID:
11821443
24.

Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma.

Santini G, Nati S, Spriano M, Gallamini A, Pierluigi D, Congiu AM, Truini M, Rubagotti A, Chisesi T, Vimercati R, Rossi E, Sertoli MR, Mattei D, Marino G, Gobbi M.

Haematologica. 2001 Mar;86(3):282-6.

25.

Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients.

Palumbo A, Triolo S, Baldini L, Callea V, Capaldi A, De Stefano V, Grasso M, Liberati M, Lotesoriere C, Marcenò R, Marmont F, Musto P, Petrucci MT, Spriano M, Pileri A, Boccadoro M.

Haematologica. 2000 May;85(5):508-13.

26.

Alpha-interferon as induction and maintenance therapy in hairy cell leukemia: a long-term follow-up analysis.

Damasio EE, Clavio M, Masoudi B, Isaza A, Spriano M, Rossi E, Casciaro S, Cerri R, Risso M, Nati S, Siccardi M, Truini M, Gobbi M.

Eur J Haematol. 2000 Jan;64(1):47-52.

PMID:
10680705
27.

Alpha-interferon as induction and maintenance therapy in hairy-cell leukemia: a long-term follow-up analysis.

Clavio M, Masoudi B, Spriano M, Casciaro S, Gobbi M, Damasio EE.

Haematologica. 1999 May;84(5):466-8. No abstract available.

28.

High-dose cyclophosphamide followed by autografting can improve the outcome of relapsed or resistant non-Hodgkin's lymphomas with involved or hypoplastic bone marrow.

Santini G, De Souza C, Congiu AM, Nati S, Marino G, Soracco M, Sertoli MR, Rubagotti A, Spriano M, Vassallo F, Rossi E, Vimercati R, Piaggio G, Figari O, Benvenuto F, Abate M, Truini M, Ravetti JL, Ribizzi I, Damasio E.

Leuk Lymphoma. 1999 Apr;33(3-4):321-30.

PMID:
10221512
29.

First line Fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual disease.

Clavio M, Miglino M, Spriano M, Pietrasanta D, Vallebella E, Celesti L, Canepa L, Pierri I, Cavaliere M, Ballerini F, Beltrami G, Rossi E, Vimercati R, Bruni R, Congiu M, Nati S, Damasio E, Santini G, Gobbi M.

Eur J Haematol. 1998 Sep;61(3):197-203.

PMID:
9753416
30.

VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.

Santini G, Salvagno L, Leoni P, Chisesi T, De Souza C, Sertoli MR, Rubagotti A, Congiu AM, Centurioni R, Olivieri A, Tedeschi L, Vespignani M, Nati S, Soracco M, Porcellini A, Contu A, Guarnaccia C, Pescosta N, Majolino I, Spriano M, Vimercati R, Rossi E, Zambaldi G, Mangoni L, Rizzoli V, et al.

J Clin Oncol. 1998 Aug;16(8):2796-802.

PMID:
9704732
31.

Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvement.

Santini G, Congiu AM, Nati S, Canepa L, Spriano M, Chisesi T, Rossi E, Vimercati R, Sertoli MR, Figari O, Gobbi M, Piaggio G, Vassallo F, Benvenuto F, Soracco M, Miglino M, Ravetti JL, Truini M.

Leuk Lymphoma. 1997 Dec;26 Suppl 1:83-8.

PMID:
9570684
32.

Five day intermittent vs seven day continuous 2-chlorodeoxyadenosine infusion for the treatment of hairy cell leukemia. A study by Italian Group for the Hairy Cell Leukemia.

Damasio EE, Resegotti L, Masoudi B, Bruni R, Cerri R, Isaza A, Clavio M, Risso M, Rossi E, Spriano M, Truini M.

Recenti Prog Med. 1998 Feb;89(2):68-73.

PMID:
9558908
33.

Anaplastic large cell lymphoma: a clinicopathologic study of 53 patients.

Clavio M, Rossi E, Truini M, Carrara P, Ravetti JL, Spriano M, Vimercati AR, Santini G, Canepa L, Pierri I, Celesti L, Miglino M, Castellaneta A, Damasio E, Gobbi M.

Leuk Lymphoma. 1996 Jul;22(3-4):319-27.

PMID:
8819081
34.

Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvement.

Santini G, Congiu AM, Nati S, Pierluigi D, Spriano M, Chisesi T, Rossi E, Vimercati R, Sertoli MR, Figari O, Gobbi M, Piaggio G, Vassallo F, Benvenuto F, Soracco M, Miglino M, Bruni R, Ravetti JL, Truini M.

Leukemia. 1996 Jun;10 Suppl 2:s88-91.

PMID:
8649061
35.

Multiple myeloma in the elderly: clinical features and response to treatment in 113 patients.

Clavio M, Casciaro S, Gatti AM, Spriano M, Bonanni F, Poggi A, Vallebella E, Pietrasanta D, Prencipe E, Goretti R, Vimercati R, Rossi E, Masoudi B, Ghio R, Boccaccio P, Ricciardi S, Damasio E, Gobbi M.

Haematologica. 1996 May-Jun;81(3):238-44.

37.

Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapy.

Carella AM, Prencipe E, Pungolino E, Lerma E, Frassoni F, Rossi E, Giordano D, Occhini D, Gatti AM, Bruni R, Spriano M, Nati S, Pierluigi D, Congiu M, Vimercati R, Ravetti JL, Federico M.

Leuk Lymphoma. 1996 Mar;21(1-2):63-70.

PMID:
8907271
38.

Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.

Cazzola M, Messinger D, Battistel V, Bron D, Cimino R, Enller-Ziegler L, Essers U, Greil R, Grossi A, Jäger G, LeMevel A, Najman A, Silingardi V, Spriano M, van Hoof A, Ehmer B.

Blood. 1995 Dec 15;86(12):4446-53.

39.

Hemophagocytic lymphohistiocytosis: still a morphological diagnosis.

Marmont AM, Spriano M.

Haematologica. 1995 Sep-Oct;80(5):480-1. No abstract available.

40.

Autologous stem cell transplantation as adjuvant treatment vs no further therapy for poor-risk Hodgkin's disease in first complete remission after MOPP/ABVD.

Carella AM, Pollicardo N, Pungolino E, Frassoni F, Giordano D, Bruni R, Spriano M, Rossi E.

Leuk Lymphoma. 1995;15 Suppl 1:59-61. No abstract available.

PMID:
7539318
41.

Fludarabine in untreated and previously treated B-CLL patients: a report on efficacy and toxicity.

Spriano M, Clavio M, Carrara P, Canepa L, Miglino M, Pierri I, Celesti L, Rossi E, Vimercati R, Bruni R, et al.

Haematologica. 1994 May-Jun;79(3):218-24.

42.

Impact of interferon at induction chemotherapy and maintenance treatment for multiple myeloma. Preliminary results of a multicenter study by the Italian non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG).

Capnist G, Vespignani M, Spriano M, Damasio E, Craviotto L, Rizzoli V, Contu A, Olmeo N, Tedeschi L, Fabris P, et al.

Acta Oncol. 1994;33(5):527-9.

PMID:
7522487
43.

HIV-related thrombocytopenia: a therapeutical update.

Rossi E, Damasio E, Terragna A, Mazzarello G, Spriano M, Anselmo M.

Haematologica. 1991 Mar-Apr;76(2):141-9. Review.

PMID:
1937173
44.

Autologous Unpurged Bone Marrow Transplantation for Acute Non Lymphoblastic Leukemia in First Remission.

Carella AM, Nati S, Carlier P, Pierluigi D, Giordano D, Congiu A, Santini G, Scarpati D, Barra S, Corvo R, Vitale V, Raffo MR, Cerri R, Risso M, Spriano M, Vimercati R, Pungolino E, Bacigalupo A, Damasio E.

Leuk Lymphoma. 1991;5(1):43-7. doi: 10.3109/10428199109068103.

PMID:
27463208
45.

A New Combination of Idarubicin, Etoposide and Cytarabine in Untreated Acute Non-Lymphoblastic Leukemia.

Carella AM, Gaozza E, Piatti G, Nati S, Pungoltno E, Santini G, Giordano D, Cerri R, Risso M, Rossi E, Spriano M, Coingiu A, Carlier P, Raffo MR, Damagio E, Bacigalupo A, Marmont AM.

Leuk Lymphoma. 1990;2(5):317-22. doi: 10.3109/10428199009106467.

PMID:
27456922
46.

Aplastic anemia, malignant lymphoma and acquired immunodeficiency syndrome.

Rossi E, Gaffuri L, Spriano M, Damasio E, Rizzo F.

Haematologica. 1989 Nov-Dec;74(6):624. No abstract available.

PMID:
2628246
47.

Idarubicin in combination with intermediate-dose cytarabine in the treatment of refractory or relapsed acute leukemias.

Carella AM, Pungolino E, Piatti G, Gaozza E, Nati S, Spriano M, Giordano D, D'Amico T, Damasio E.

Eur J Haematol. 1989 Oct;43(4):309-13.

PMID:
2583257
48.

[Autoimmune hemocytopenias of the AIDS/ARC complex with special emphasis on autoimmune thrombocytopenia].

Damasio EE, Rossi E, Terragna A, Cerri R, Figari O, Mazzarello G, Pagano G, Piaggio G, Spriano M, Vimercati AR, et al.

Haematologica. 1989 Oct;74(5 Suppl):190-209. Review. Italian. No abstract available.

PMID:
2512208
49.

Successful treatment of T-hairy cell leukemia with lymphoblastoid-interferon.

Rossi E, Gualandi F, Lamparelli T, Repetto M, Nocera A, Spriano M, Occhini D, Ruggeri C, Vimercati R, Damasio EE.

J Exp Pathol. 1987 Summer;3(4):593-601. No abstract available.

PMID:
3502652
50.

Hairy cell leukemia: a retrospective study of 235 cases by the Italian Cooperative Group (ICGHCL) according to Jansen's clinical staging system.

Damasio EE, Spriano M, Repetto M, Vimercati AR, Rossi E, Occhini D, Marmont AM.

Acta Haematol. 1984;72(5):326-34.

PMID:
6441412

Supplemental Content

Loading ...
Support Center